BRCA1 and breast carcinoma: A retrospective analysis of the testing results of breast cancer patients showed that 2.6% of individuals in this group would have received a VUS result if only the BRCA1/2 genes had been tested and this percentage is increasing when other high, moderate and low risk genes are added to the testing scenario.